NEW PUBLISHED DATA

The impact of monitoring techniques on progression to chronic breast cancer‑related lymphedema: a meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurements

Chirag Shah, MD, April Zambelli‑Weiner, Nicole Delgado, Ashley Sier, Robert Bauserman, Jerrod Nelms

Meta-analysis includes:

  • 50 lymphedema studies and over 67,000 patients studied
  • Investigated BCRL in breast cancer patients
  • Analyzed impact of prospective monitoring and intervention
VIEW STUDY

3-Key Takeaways from Meta-Analysis Comparing Bioimpedance Spectroscopy vs. Circumferential Measurement

incidence - circumference vs L-Dex
 

81% Lower Rate of Chronic Lymphedema than Circumference Monitoring

This recent meta-analysis confirms that routine monitoring for early detection of lymphedema using ImpediMed's L-Dex® technology, combined with early intervention, cuts the relative rate of chronic breast cancer-related lymphedema by 81% when compared to circumference monitoring.

LEARN MORE

incidence circumference vs L-Dex high risk treatment
 

Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

The benefit is sustained in high-risk subgroups as well as short-term and long-term follow-up. L-Dex monitoring and intervention studies showed a statistically significant reduction in chronic lymphedema in studies with >50% axillary lymph node dissection (ALND), >40% mastectomy, <2 years follow-up, and >2 years follow-up when compared to circumference studies.

LEARN MORE

Incidence of Chronic Lymphedema in Short-Term and Long-Term Follow-up
 

Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

The benefit is sustained in high-risk subgroups as well as short-term and long-term follow-up. L-Dex monitoring and intervention studies showed a statistically significant reduction in chronic lymphedema in studies with >50% axillary lymph node dissection (ALND), >40% mastectomy, <2 years follow-up, and >2 years follow-up when compared to circumference studies.

VIEW STUDY

Test Trigger Treat

DOWNLOAD DATA SHEET

Reduce the incidence of Chronic Lymphedema in Breast Cancer Patients with early detection protocol Test, Trigger, Treat. Contact us to learn more.

LEARN MORE